Clinical Trial Update: An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome. [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial assessed the efficacy and safety of topiramate in treating Tourette syndrome and has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• Topiramate (Topamax) (topiramate)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Tourette Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2017-11-06